MarketCap
Facebook
X
TelegramOxford Immunotec Global PLC EBITDA per Share 2011-2026 | OXFD
Annual EBITDA per Share Oxford Immunotec Global PLC
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00122 | -0.00698 | - | - | - | 0.433 | 0.763 | 0.825 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 0.825 | -0.00698 | 0.403 |
EBITDA per Share of other stocks in the Diagnostics research industry
| Issuer | EBITDA per Share | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-0.94 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Heska Corporation
HSKA
|
-0.61 | - | - | $ 1.31 B |  USA |
 |
Agilent Technologies
A
|
5.49 | $ 115.9 | 0.73 % | $ 35.2 B | USA |
 |
Celcuity
CELC
|
-3.68 | $ 133.57 | -0.51 % | $ 6.25 B | USA |
|
Akumin
AKU
|
0.78 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Co-Diagnostics
CODX
|
-36.9 | $ 7.59 | -16.68 % | $ 10.1 M | USA |
 |
Castle Biosciences
CSTL
|
-0.07 | $ 20.94 | 6.35 % | $ 607 M | USA |
 |
Aspira Women's Health
AWH
|
-0.23 | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
-1.46 | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
-1.79 | - | -13.05 % | $ 7.29 M | USA |
 |
Fulgent Genetics
FLGT
|
-2.18 | $ 17.68 | 0.03 % | $ 544 M | USA |
 |
Guardant Health
GH
|
-3.17 | $ 125.25 | 4.51 % | $ 15.7 B | USA |
 |
CareDx, Inc
CDNA
|
-0.3 | $ 22.05 | 2.37 % | $ 1.17 B | USA |
 |
Chembio Diagnostics
CEMI
|
-0.65 | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
-0.38 | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
-22.8 | - | -20.0 % | $ 1.06 M | USA |
 |
Interpace Biosciences
IDXG
|
1.02 | $ 1.8 | - | $ 7.96 M | USA |
 |
ICON Public Limited Company
ICLR
|
19.2 | $ 117.6 | 3.29 % | $ 9.7 B |  Irlanda |
 |
Illumina
ILMN
|
-3.01 | $ 151.1 | 4.05 % | $ 24 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.37 | - | - | $ 399 M |  China |
 |
Lantheus Holdings
LNTH
|
5.64 | $ 99.53 | -0.53 % | $ 6.72 B | USA |
 |
Genetic Technologies Limited
GENE
|
-1.27 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-1.12 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
-3.17 | - | -11.32 % | $ 2.94 M | USA |
 |
Mettler-Toledo International
MTD
|
2.48 | $ 1 093.48 | -0.71 % | $ 22.5 B |  Schweiz |
 |
Charles River Laboratories International
CRL
|
8.64 | $ 163.66 | 4.54 % | $ 8.11 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
8.68 | - | - | $ 10.7 B | USA |
 |
NeoGenomics
NEO
|
-0.62 | $ 9.52 | 2.7 % | $ 1.22 B | USA |
 |
Enzo Biochem
ENZ
|
-218 | - | -8.98 % | $ 14.8 K | USA |
 |
Medpace Holdings
MEDP
|
19.5 | $ 430.27 | 0.27 % | $ 12.4 B | USA |
 |
National Research Corporation
NRC
|
1.35 | $ 19.04 | - | $ 426 M | USA |
 |
Natera
NTRA
|
-5.33 | $ 203.17 | 1.12 % | $ 20 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-0.43 | - | - | $ 19.8 B | USA |
 |
Myriad Genetics
MYGN
|
-3.6 | $ 3.91 | 1.56 % | $ 362 M | USA |
 |
Personalis
PSNL
|
-0.87 | $ 9.35 | 4.53 % | $ 834 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
2.69 | $ 26.55 | -1.5 % | $ 25.2 B |  Niderland |
 |
Senseonics Holdings
SENS
|
-1.6 | $ 6.27 | -2.49 % | $ 262 M | USA |
 |
QIAGEN N.V.
QGEN
|
3.04 | - | - | $ 10.6 B | Niderland |
 |
Soleno Therapeutics
SLNO
|
0.22 | - | - | $ 2.69 B | USA |
 |
Biomerica
BMRA
|
-2.2 | $ 2.38 | -3.64 % | $ 5.47 M | USA |
 |
Twist Bioscience Corporation
TWST
|
-1.86 | $ 64.96 | 0.14 % | $ 3.89 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
24.8 | $ 259.0 | 0.23 % | $ 21.5 B | USA |
 |
Thermo Fisher Scientific
TMO
|
23.3 | $ 452.36 | 0.92 % | $ 171 B | USA |
 |
Waters Corporation
WAT
|
6.02 | $ 343.25 | 1.35 % | $ 20.4 B | USA |
 |
Trinity Biotech plc
TRIB
|
-0.06 | $ 0.67 | 3.54 % | $ 241 M | Irlanda |
 |
Motus GI Holdings
MOTS
|
-7.41 | - | -34.28 % | $ 263 K | Israel |
 |
Neogen Corporation
NEOG
|
-4.34 | $ 9.27 | 1.42 % | $ 2.01 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 | $ 194.63 | 0.89 % | $ 21.6 B | USA |